CVS Health Co. (NYSE:CVS) Shares Sold by YHB Investment Advisors Inc.

YHB Investment Advisors Inc. reduced its position in shares of CVS Health Co. (NYSE:CVS) by 9.2% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 12,345 shares of the pharmacy operator’s stock after selling 1,245 shares during the period. YHB Investment Advisors Inc.’s holdings in CVS Health were worth $554,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in CVS. MidAtlantic Capital Management Inc. acquired a new stake in shares of CVS Health in the 3rd quarter valued at approximately $25,000. Ridgewood Investments LLC boosted its position in shares of CVS Health by 255.7% during the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 450 shares in the last quarter. Livelsberger Financial Advisory acquired a new position in shares of CVS Health during the 3rd quarter worth $31,000. Legacy Investment Solutions LLC acquired a new stake in shares of CVS Health in the third quarter valued at about $31,000. Finally, Reston Wealth Management LLC purchased a new stake in CVS Health during the third quarter worth about $32,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Stock Up 2.2 %

Shares of NYSE:CVS opened at $57.45 on Wednesday. CVS Health Co. has a 12-month low of $43.56 and a 12-month high of $80.75. The stock’s 50-day moving average price is $51.24 and its two-hundred day moving average price is $56.19. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The firm has a market cap of $72.29 billion, a price-to-earnings ratio of 14.58, a PEG ratio of 0.80 and a beta of 0.59.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.08 by $0.01. The firm had revenue of $95.43 billion during the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. CVS Health’s revenue for the quarter was up 6.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.21 earnings per share. On average, research analysts forecast that CVS Health Co. will post 5.22 EPS for the current year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be paid a dividend of $0.665 per share. The ex-dividend date of this dividend is Thursday, January 23rd. This represents a $2.66 annualized dividend and a yield of 4.63%. CVS Health’s dividend payout ratio is presently 67.51%.

Analyst Upgrades and Downgrades

CVS has been the subject of a number of research reports. Royal Bank of Canada reduced their price target on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a research report on Friday, November 15th. Truist Financial decreased their target price on CVS Health from $67.00 to $60.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Mizuho dropped their price target on CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research report on Thursday, October 24th. Piper Sandler decreased their price objective on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a research report on Monday, November 25th. Finally, StockNews.com downgraded shares of CVS Health from a “hold” rating to a “sell” rating in a report on Thursday, November 14th. One analyst has rated the stock with a sell rating, six have issued a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $68.12.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.